BCL2L1 and cancer: Mechanistic studies using cultured cancer cells have also revealed SFN-mediated suppression of various oncogenic pathways often hyperactive in human cancers, including nuclear factor-κB, androgen receptor, Bcl-2, Bcl-xL, and signal transducer and activator of transcription 3 [14], [21]–[23].